In contrast, CHI3L1 and OPN correlated with markers of tissue damage and could potentially hold prognostic value for the extent of recovery in ON and possibly for the disability progression in MS after repeated relapses. This evidence concerns the gene CHI3L1 and myeloid sarcoma.